1-15 of 15 results for subject:"Independent Review Panel for Advertising"
Librarians' tools
- Search time
- 0.247 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:"Independent Review Panel for Advertising"
- We searched for
- subject_t:"Independent Review Panel for Advertising" OR subject_t:"Medicines Advertising Regulations Independent Review Panel" OR subject_ses:26625
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
I have received the annual report of the Medicines Commission for 2004, which has been laid before Parliament today in accordance with the requirements of section 5(2) of the Medicines Act 1968. Bound volumes have been placed in the Library containing the 2004 reports of the Medicines Commission, the Committee...
I have received the annual report of the Medicines Commission for 2004, which has been laid before Parliament today in accordance with the requirements of section 5(2) of the Medicines Act 1968. Bound volumes have been placed in the Library containing the 2004 reports of the Medicines Commission, the Committee...
My right honourable friend the Minister of State (Jane Kennedy) has made the following Written Ministerial Statement. I have received the annual report of the Medicines Commission for 2004, which has been laid before Parliament today in accordance with the requirements of Section 5(2) of the Medicines Act 1968. Bound...
My right honourable friend the Minister of State (Jane Kennedy) has made the following Written Ministerial Statement. I have received the annual report of the Medicines Commission for 2004, which has been laid before Parliament today in accordance with the requirements of Section 5(2) of the Medicines Act 1968. Bound...
Medicines Act 1968 Advisory Bodies Annual Reports 2004. 224 p.
Medicines Act 1968 Advisory Bodies Annual Reports 2004. 224 p.
In the light of the comment of Lord Hunt of Kings Heath on 11 May that 'we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people' (HL Deb. c1089), to serve on the independent review panel, why in the review decisions on advertisements to...
In the light of the comment of Lord Hunt of Kings Heath on 11 May that 'we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people' (HL Deb. c1089), to serve on the independent review panel, why in the review decisions on advertisements to...
Why Consumers for Health Choice and the National Association of Health Stores were not included by the Medicines Control Agency in the circulation of the consultation letter dated 29 April about membership of the Independent Review Panel for Advertising of Medicines; why earlier commitments to involve these organisations in relevant...
Why Consumers for Health Choice and the National Association of Health Stores were not included by the Medicines Control Agency in the circulation of the consultation letter dated 29 April about membership of the Independent Review Panel for Advertising of Medicines; why earlier commitments to involve these organisations in relevant...
In the light of the reply given by the Lord Hunt of Kings Health on 11 May 1999, 600 c1088-91, that "we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people" to serve on the independent review panel which will review decisions on advertisements...
In the light of the reply given by the Lord Hunt of Kings Health on 11 May 1999, 600 c1088-91, that "we are consulting with industry, professional and consumer interests on the nomination of suitably qualified people" to serve on the independent review panel which will review decisions on advertisements...
Whether the proposed independent panel which will review preliminary decisions on advertising under Regulation 13 of the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999 (SI No 267) will: (a) invite all interested parties to present oral or written evidence on an equal access basis; (b) be able to...
Whether the proposed independent panel which will review preliminary decisions on advertising under Regulation 13 of the Medicines (Advertising and Monitoring of Advertising) Amendment Regulations 1999 (SI No 267) will: (a) invite all interested parties to present oral or written evidence on an equal access basis; (b) be able to...